Cargando…
Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease
Intestinal fibrosis is one of the most threatening complications of Crohn’s disease. It occurs in more than a third of patients with this condition, is associated with increased morbidity and mortality, and surgery often represents the only available therapeutic option. The mechanisms underlying int...
Autores principales: | Santacroce, Giovanni, Lenti, Marco Vincenzo, Di Sabatino, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834168/ https://www.ncbi.nlm.nih.gov/pubmed/35159238 http://dx.doi.org/10.3390/cells11030429 |
Ejemplares similares
-
Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis
por: Di Sabatino, Antonio, et al.
Publicado: (2023) -
The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis
por: Biancheri, Paolo, et al.
Publicado: (2013) -
Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
por: Santacroce, Giovanni, et al.
Publicado: (2023) -
Liver-spleen axis dysfunction in COVID-19
por: Cococcia, Sara, et al.
Publicado: (2021) -
Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)